NCT03567980View on ClinicalTrials.gov

A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

April 30, 2020

Study Completion Date

May 12, 2021

Conditions
Seborrheic Dermatitis
Interventions
DRUG

Crisaborole

Application of topical crisaborole 2% ointment on the face for 4 weeks to evaluate the anti-inflammatory action of this agent and its utility in the treatment of facial seborrheic dermatitis.

Trial Locations (1)

35249

Dermatology at the Whitaker Clinic, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT03567980 - A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis | Biotech Hunter | Biotech Hunter